| scholarly article | Q13442814 |
| P356 | DOI | 10.3109/10428194.2013.869801 |
| P8608 | Fatcat ID | release_quo6r24j3fbrrmjbkjhomjsw4m |
| P932 | PMC publication ID | 4419693 |
| P698 | PubMed publication ID | 24286263 |
| P50 | author | Clive S Zent | Q57078355 |
| Susan L Slager | Q92530010 | ||
| Timothy G. Call | Q110903651 | ||
| Susan M. Schwager | Q110920181 | ||
| Kari G Rabe | Q56885267 | ||
| P2093 | author name string | David S Viswanatha | |
| Gregory A Wiseman | |||
| Deborah A Bowen | |||
| Michael J Conte | |||
| P2860 | cites work | Chromosome anomalies detected by interphase fluorescence in situ hybridization: correlation with significant biological features of B-cell chronic lymphocytic leukaemia | Q73267761 |
| Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia | Q77637148 | ||
| Predictive value of blood and bone marrow flow cytometry in B-cell lymphoma classification: comparative analysis of flow cytometry and tissue biopsy in 252 patients | Q81610592 | ||
| Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines | Q24616084 | ||
| Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia ("accelerated" chronic lymphocytic leukemia) with aggressive clinical behavior | Q34095636 | ||
| Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas. | Q34362370 | ||
| National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment | Q34382878 | ||
| CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential | Q35769292 | ||
| Immunoglobulin diversity gene usage predicts unfavorable outcome in a subset of chronic lymphocytic leukemia patients | Q36227244 | ||
| Positron emission tomographic scans in lymphoma: convention and controversy | Q36399538 | ||
| Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma | Q37163867 | ||
| Infectious complications of chronic lymphocytic leukaemia: pathogenesis, spectrum of infection, preventive approaches | Q37771673 | ||
| Fundamentals of PET and PET/CT imaging | Q37896129 | ||
| Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL). | Q43695199 | ||
| 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography examination in patients with chronic lymphocytic leukemia may reveal Richter transformation. | Q44438293 | ||
| Veterans with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) have a markedly increased rate of second malignancy, which is the most common cause of death | Q44560759 | ||
| ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia | Q46112511 | ||
| Proliferation centers in chronic lymphocytic leukemia: correlation with cytogenetic and clinicobiological features in consecutive patients analyzed on tissue microarrays. | Q50790201 | ||
| Detection of Richter's transformation of chronic lymphocytic leukemia by PET/CT. | Q53343426 | ||
| Role of fluorine-18 fluoro-deoxyglucose positron emission tomography scan in the evaluation and follow-up of patients with low-grade lymphomas. | Q53536740 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | leukemia | Q29496 |
| lymphocyte | Q715347 | ||
| P304 | page(s) | 2079-2084 | |
| P577 | publication date | 2014-02-17 | |
| P1433 | published in | Leukemia & Lymphoma | Q6534493 |
| P1476 | title | Use of positron emission tomography-computed tomography in the management of patients with chronic lymphocytic leukemia/small lymphocytic lymphoma | |
| P478 | volume | 55 |
| Q52990703 | An 18F-FDG-PET maximum standardized uptake value > 10 represents a novel valid marker for discerning Richter's Syndrome. |
| Q36826893 | Chronic lymphocytic leukemia/small lymphocytic lymphoma, version 1.2015 |
| Q41481956 | Diagnostic and prognostic role of PET/CT in patients with chronic lymphocytic leukemia and progressive disease. |
| Q36000944 | Dinaciclib is a novel cyclin-dependent kinase inhibitor with significant clinical activity in relapsed and refractory chronic lymphocytic leukemia |
| Q37632114 | FDG-PET imaging in hematological malignancies |
| Q40291554 | Factors predicting survival in chronic lymphocytic leukemia patients developing Richter syndrome transformation into Hodgkin lymphoma |
| Q37636962 | How we treat Richter syndrome |
| Q39152872 | Inappropriateness of diagnostic imaging examinations in the inpatient setting: a case study research |
| Q64111287 | Multimodality imaging of indolent B cell lymphoma from diagnosis to transformation: what every radiologist should know |
| Q34908079 | Potential role of (18)F-2-fluoro-2-deoxy-glucose positron emission tomography/computed tomography imaging in patients presenting with generalized lymphadenopathy. |
| Q40037434 | Richter Syndrome in Chronic Lymphocytic Leukemia |
| Q38248873 | Risk factors for Richter syndrome in chronic lymphocytic leukemia |
Search more.